Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
Articles by Patrícia Silva
Recent Posts
- Tavneos found safe, effective for AAV patients in real-world study July 24, 2024
- Using asthma medication off-label leads to disease remission in EGPA July 22, 2024
- New B-cell growth is impaired in AAV, study finds July 17, 2024
- Large-vessel involvement in AAV tied to neurological manifestations July 15, 2024
- Kidney failure risk factors ID’d in children with AAV kidney disease July 10, 2024
- Asthma drug may trigger rare ANCA-associated vasculitis July 8, 2024
- Nkarta gets green light from FDA to test NKX019 cell therapy in AAV July 3, 2024
- Tavneos better than prednisone for treating ear, nose, throat symptoms July 1, 2024
- Melodia buys rights to potential AAV therapy MDI-0151 June 26, 2024
- FDA clears Phase 2 trial of antibody therapy ruxoprubart in AAV June 24, 2024